+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 21Years - 90Years
All Genders
ID06689839

Randomized Study Comparing the Encompass F2 Cerebral Protection Catheter to No Embolic Protection During Transfemoral Transcatheter Aortic Valve Replacement

Led by EnCompass Technologies, Inc. · Updated on 2026-10-30

500

Participants Needed

10

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and effectiveness of the F2 Cerebral Protection Catheter CPC compared to a control group without embolic protection in adults undergoing transfemoral Transcatheter Aortic Valve Replacement TF TAVR. The study aims to show that the F2 CPC is as safe as no protection and performs better in preventing embolic events during the procedure. This is a prospective, randomized, single-blind trial involving multiple centers. Participants will be assigned randomly to one of two groups one group will receive the F2 Cerebral Embolic Protection System during their TF TAVR procedure, while the control group will undergo the procedure without any embolic protection device. The study uses commercially available TAVR devices and compares outcomes between these two approaches. This treatment phase focuses on the procedure itself and the use or non-use of the F2 CPC device. During and after the procedure, participants will be closely monitored for neurological protection effectiveness and major adverse events up to 30 days post-procedure. Assessments include brain imaging with diffusion-weighted MRI within 8 to 72 hours after the procedure and evaluations of safety and vascular complications by discharge or day 5 to 10, with follow-up on day 30. Participants will undergo various tests and evaluations to measure brain lesions, kidney function, bleeding, and vascular complications, ensuring thorough monitoring throughout the study period.

CONDITIONS

Brief Title

Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR

Research Team

S

Sandra Show

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here